Carvacrol encapsulated nanocarrier/ nanoemulsion abrogates angiogenesis by downregulating COX-2, VEGF and CD31 in vitro and in vivo in a lung adenocarcinoma model.
作者:
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞增殖(Cell Proliferation);环氧化酶2(Cyclooxygenase 2);减量调节(Down-Regulation);药物载体(Drug Carriers);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);乳状剂(Emulsions);人类(Humans);肺肿瘤(Lung Neoplasms);小鼠(Mice);纳米粒子(Nanoparticles);肿瘤, 实验性(Neoplasms, Experimental);新生血管化, 病理性(Neovascularization, Pathologic);粒子大小(Particle Size);表面特性(Surface Properties);肿瘤细胞, 培养的(Tumor Cells, Cultured);血管内皮生长因子类(Vascular Endothelial Growth Factors)
DOI
10.1016/j.colsurfb.2019.06.016
PMID
31202132
发布时间
2020-01-31
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文